Bircan, K. Et Al. 1990. Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH). International Urology and Nephrology , vol.22, no.4 , 345-348.

Bircan, K., ÖZEN, H., Ergen, A., Başar, I., Özgür, S., Ilker, Y., ... Karaaĝaoĝlu, E.(1990). Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH). International Urology and Nephrology , vol.22, no.4, 345-348.

Bircan, K. Et Al. "Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)," International Urology and Nephrology , vol.22, no.4, 345-348, 1990

Bircan, K. Et Al. "Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)." International Urology and Nephrology , vol.22, no.4, pp.345-348, 1990

Bircan, K. Et Al. (1990) . "Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)." International Urology and Nephrology , vol.22, no.4, pp.345-348.

@article{article, author={K. Bircan Et Al. }, title={Raveron® versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)}, journal={International Urology and Nephrology}, year=1990, pages={345-348} }